Xylo Technologies Ltd (XYLO) AI Stock Analysis

• Market Cap: $3.92M
• Dividend Yield: N/A
• Average Volume (3M): 11.24K
• Price to Earnings (P/E): ―
• Beta (1Y): 0.23
• Revenue Growth: -47.53%
• EPS Growth: 0.67%
• Country: US
• Employees: 84
• Sector: Healthcare
• Sector Strength: 74
• Industry: Medical - Devices
• EPS (TTM): -23.59
• Shares Outstanding: 747,332
• 10 Day Avg. Volume: 5,712
• 30 Day Avg. Volume: 11,242
• PEG Ratio: N/A
• Price to Book (P/B): N/A
• Price to Sales (P/S): 0.04
• Price to Cash Flow (P/CF): N/A
• P/FCF Ratio: 0.00
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0

Xylo Technologies Ltd faces major financial challenges, with persistent losses and negative cash flow, which are significant risks. However, the technical indicators show positive momentum, suggesting some short-term optimism. The poor valuation metrics, including a negative P/E ratio, limit the stock's attractiveness. Overall, while there are signs of market interest, the underlying financial weaknesses keep the score moderate.

Xylo Technologies Ltd Business Overview & Revenue Model

Company Description

Xylo Technologies Ltd, a technology-based company, provides medical-related devices and products in the United States, Europe, Asia, Israel, and internationally. The company operates through Corporate, E-commerce, Online Advertising & Internet Traffic Routing, Online Event Management, and Others segments. It offers Medigus Ultrasonic Surgical Endostapler, an endoscopy system, which is used for the treatment of gastroesophageal reflux disease. The company also develops biological gels to protect patients against biological threats and reduce the intrusion of allergens and viruses through the upper airways and eye cavities. In addition, it provides digital advertising platform; and operates online stores for the sale of various consumer products on the Amazon online marketplace, as well as an online event management and ticketing platform. Further, the company develops wireless vehicle battery charging technologies and modular electronic vehicles. The company was formerly known as Medigus Ltd. and changed its name to Xylo Technologies Ltd in April 2024. Xylo Technologies Ltd was incorporated in 1999 and is headquartered in Tel Aviv-Yafo, Israel.

How the Company Makes Money

Xylo Technologies Ltd Financial Statement Overview

Summary

Overall, Xylo Technologies Ltd is grappling with significant financial challenges across its income statement, balance sheet, and cash flow. The company struggles with profitability, despite revenue growth, and faces cash flow issues that could impact its ability to sustain operations. While its debt position is not critically high, declining equity and persistent losses pose long-term financial risks.

Income Statement

Xylo Technologies Ltd has faced significant challenges in maintaining profitability, as indicated by its negative EBIT and net income over multiple years. Although revenue has increased substantially since 2019, gross profit margins remain low or negative, suggesting cost control issues. The lack of positive revenue growth in the most recent year compounds these concerns.

Balance Sheet

The balance sheet shows a moderate level of financial stability with a debt-to-equity ratio that is manageable, supported by a relatively higher equity ratio. However, the decline in stockholders' equity over recent years highlights potential vulnerabilities. While the company's total liabilities have increased over the years, the debt levels are not excessively high, which provides some comfort.

Cash Flow

The cash flow statement reveals persistent negative operating cash flow and free cash flow, indicating financial strain. The company's ability to convert operating profits into cash is weak, as evidenced by negative free cash flow to net income ratios. The growth of free cash flow is also negative, highlighting ongoing challenges in cash generation.

Breakdown
TTM	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019
Income Statement		Total Revenue
57.64M	91.72M	91.86M	10.12M	531.00K	273.00K
	Gross Profit
7.80M	11.84M	14.45M	4.80M	-503.00K	-182.00K
	EBIT
-17.94M	-23.32M	-8.58M	-8.20M	-7.46M	-4.20M
	EBITDA
-5.20M	-16.30M	-5.38M	6.99M	-7.30M	-13.89M
	Net Income Common Stockholders
-15.99M	-16.02M	-9.81M	6.79M	-4.33M	-14.18M
Balance Sheet		Cash, Cash Equivalents and Short-Term Investments
25.23M	12.54M	25.23M	27.34M	22.36M	7.04M
	Total Assets
97.65M	63.90M	97.65M	59.73M	32.34M	13.33M
	Total Debt
10.13M	9.79M	10.13M	1.62M	107.00K	152.00K
	Net Debt
-10.12M	429.00K	-10.12M	-22.41M	-22.26M	-6.88M
	Total Liabilities
42.96M	31.46M	42.96M	8.30M	6.14M	5.20M
	Stockholders Equity
39.14M	23.58M	39.14M	49.19M	22.96M	6.71M
Cash Flow		Free Cash Flow
-4.15M	-7.99M	-5.73M	-10.39M	-6.47M	-2.76M
	Operating Cash Flow
-4.11M	-6.25M	-5.66M	-5.25M	-6.14M	-2.69M
	Investing Cash Flow
2.73M	-4.06M	-4.48M	-12.21M	-1.60M	-917.00K
	Financing Cash Flow
-4.27M	-524.00K	5.41M	18.92M	22.95M	-46.00K

Xylo Technologies Ltd Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 5.20
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For XYLO, the sentiment is Positive. The current price of 5.2 is above the 20-day moving average (MA) of 5.03, above the 50-day MA of 4.73, and above the 200-day MA of 4.07, indicating a bullish trend. The MACD of 0.13 indicates Positive momentum. The RSI at 54.35 is Neutral, neither overbought nor oversold. The STOCH value of 37.22 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for XYLO.

Xylo Technologies Ltd Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
ACN	75 Outperform	$187.77B	24.75	27.26%	1.85%	4.10%	9.78%
INFY	75 Outperform	$67.64B	22.12	33.16%	2.53%	3.08%	11.92%
CTSH	72 Outperform	$36.05B	16.17	16.21%	1.82%	1.98%	7.16%
WIT	68 Neutral	$28.72B	26.98	16.59%	2.13%	-3.41%	67.87%
XYLO	53 Neutral	$3.92M	―	-68.97%	―	-47.53%	0.67%
Sector *	48 Neutral	$6.36B	1.28	-45.04%	2.64%	19.24%	1.69%
DXC	47 Neutral	$2.82B	267.98	-2.46%	―	-5.65%	78.20%